Kelly John Alexander 4

4 · PRECISION BIOSCIENCES INC · Filed Jan 22, 2025

Form 4

Period: 2025-01-20

Chief Financial Officer

Transactions

Exercise/Conversion
Restricted Stock Units
2025-01-20−3,889→ 3,888 total
→ Common Stock (3,889 underlying)
Exercise/Conversion
Restricted Stock Units
2025-01-20−13,904→ 27,801 total
→ Common Stock (13,904 underlying)
Exercise/Conversion
Common Stock
2025-01-20+44,368→ 84,554 total
Exercise/Conversion
Restricted Stock Units
2025-01-20−26,575→ 53,150 total
→ Common Stock (26,575 underlying)

Footnotes (5)

[F1]Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2025.
[F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
[F3]On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
[F4]On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
[F5]On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Documents

1 file